Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) -24.46-22.972.447.39-57.36

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -24.46 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar2024-24.46
Mar2023-22.97
Mar20222.44
Mar20217.39
Mar2020-57.36

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44
-66.98
Mar2021 7.39
Positive
Mar2020 -57.36 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹253.6 Cr -0.6% -11.6% 27.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹381,686.0 Cr -2.5% -0.2% -15.2% Stock Analytics
DIVIS LABORATORIES ₹151,241.0 Cr -5.9% -6.9% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,339.0 Cr -1.9% 0.7% 3.9% Stock Analytics
CIPLA ₹120,240.0 Cr -2.6% -6.4% -8.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,091.0 Cr -5.6% -2.2% -6.4% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-0.6%

-11.6%

27.9%

SENSEX

-2.2%

0.4%

-5.4%


You may also like the below Video Courses